glaucoma therapy (Houston)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameglaucoma therapy (Houston)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGlaucoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHouston Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHouston Biotechnology Inc

Active IndicationsN/A

Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A